arrow_back Back to App

Recognizing DES Drug Harm, Supporting Research, and Urging FDA Apology.

This resolution aims to officially acknowledge the historical health damage caused by the drug DES, which was administered to pregnant women until 1971. It calls for the restoration of funding for research into the long-term effects of this drug and urges the FDA to issue a formal apology to the affected families. This action supports individuals whose health was compromised by this toxic substance, including children exposed to cancer and fertility issues.
Key points
Support for restoring funding for the DES Follow-Up Study to investigate the long-term health consequences of exposure, crucial for affected generations.
Urging the Food and Drug Administration (FDA) to issue a formal apology to the millions of families impacted by the use of the DES drug.
Designating April 20-26 as DES Awareness Week to increase public knowledge about the risks and support those affected.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HRES_342
Sponsor: Rep. McGovern, James P. [D-MA-2]
Process start date: 2025-04-21
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Recognizing the history of the drug diethylstilbestrol and the harm it has caused, and for other purposes.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HRES_342.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-04-21.

What are the main provisions?

Key points include:

  • Support for restoring funding for the DES Follow-Up Study to investigate the long-term health consequences of exposure, crucial for affected generations.
  • Urging the Food and Drug Administration (FDA) to issue a formal apology to the millions of families impacted by the use of the DES drug.
  • Designating April 20-26 as DES Awareness Week to increase public knowledge about the risks and support those affected.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. McGovern, James P. [D-MA-2].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

CATEGORIES

Health